News & Blogs

Three More Companies Trust in SOCMA for Solutions and Growth

Three new companies were approved to join the growing membership of the Society of Chemical Manufacturers & Affiliates (SOCMA) by its Board of Governors last week. The addition of Advanced Chemical Concepts (ACC), Revtech and Texas Molecular brings the total number of new members to 11 in the first five months of the year.

May 29, 2020

OSHA Revises Guidances on COVID-19 Recordkeeping & Enforcement

OSHA has issued two revised guidance memos on recordkeeping and enforcement in response to the COVID-19 pandemic. On May 26, 2020, the previous memos from April on these topics will be rescinded, and the new memos will go into and remain in effect until further notice.

May 20, 2020

CJB Applied Technologies, LLC Welcomes James M. Loar as Chief Commercial Officer

CJB Applied Technologies, LLC is pleased to announce James M. Loar ("Jim") has joined the company as Chief Commercial Officer, where he will lead global commercial activities related to innovation, contract development and manufacturing.

May 20, 2020

Demographics Show Positive Outlook for Post-COVID Economy

Internationally respected demographer, Ken Gronbach, stated the U.S. economy would not suffer as a result of COVID-19 because of it's position in the global landscape.

May 14, 2020

SOCMA Safety Solutions and Core Considerations for Reintegrating Employees Back into the Workplace

In this post, SOCMA shares the following core considerations for developing return to work plans. The following information was compiled based on information shared during a SOCMA roundtable with DanChem, Strem Chemicals, Inc and Sun Chemical Corporation. A template return to work plan is in development and will be available in the coming week.

May 8, 2020

COVID-19 | Customer Letter | Advanced Chemical Concepts

Customer letter from Advanced Chemical Concepts to address COVID-19 challenges.

May 6, 2020

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus

Moderna, Inc. and Lonza Ltd. today announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional Moderna products in the future.

May 5, 2020

LATEST NEWS IN SPECIALTY CHEMICALS

Latest Updates